IVIg in the chronic management of myasthenia gravis: Is it enough for your money?

Journal of the Neurological Sciences

Volumn 338, Issue 1-2, 2014, Pages 1-2

  Dalakas, Marinos C ^a,b  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; MONOCLONAL ANTIBODY; PREDNISONE;

COST; EDITORIAL; HUMAN; LONG TERM CARE; MYASTHENIA GRAVIS; NONHUMAN; PLASMAPHERESIS; PRIORITY JOURNAL; QUALITY OF LIFE; TREATMENT RESPONSE;

FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MALE; MYASTHENIA GRAVIS;

EID: 84896708221     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2013.12.034     Document Type: Editorial

References (12)

1. M.C. Dalakas Biologics and other novel approaches and new therapeutic options in myasthenia gravis: a view to the future Ann N Y Acad Sci 1274 2012 168 175
2. D.B. Drachman Therapy of myasthenia gravis Handb Clin Neurol 91 2008 253 272
3. D.B. Sanders, and A. Evoli Immunosuppressive therapies in myasthenia gravis Autoimmunity 43 5-6 2010 428 435
4. M.C. Dalakas Novel future therapeutic options in myasthenia gravis Autoimmun Rev 12 2013 936 941
5. M.C. Dalakas Evidence-based efficacy of intravenous immunoglogulin in human myasthenia gravis and mechanisms of action Premkumar Christadoss, Myasthenia gravis: mechanisms of disease and immune intervention 2010 Linus Publication, Inc. New York 89 102
6. P. Gajdos, S. Chevret, and K. Toyka Intravenous immunoglobulin for myasthenia gravis Cochrane Database Syst Rev 1 2008 CD002277
7. M.C. Dalakas Advances in the diagnosis, pathogenesis and treatment of CIDP Nat Rev Neurol 7 9 2011 507 517
8. M.A. Hellmann, R. Mosberg-Galili, I. Lotan, and I. Steiner Maintenance IVIg therapy in myasthenia gravis does not affect disease activity J Neurol Sci 338 2014 39 42
9. M.C. Dalakas Immunotherapy of inflammatory myopathies: practical approach and future prospects Curr Treat Options Neurol 13 3 2011 311 323
10. N. Collongues, O. Casez, A. Lacour, C. Tranchant, P. Vermersch, J. de Seze, and C. Lebrun Rituximab in refractory and non-refractory myasthenia: a retrospective multicenter study Muscle Nerve 46 5 2012 Nov 687 691 [Epub 2012 Aug 31]
11. J. Díaz-Manera, E. Martínez-Hernández, L. Querol, R. Klooster, R. Rojas-García, and X. Suárez-Calvet et al. Long-lasting treatment effect of rituximab in MuSK myasthenia Neurology 78 3 2012 189 193
12. J.F. Howard, R.J. Barhon, and G.R. Cutter et al. A randomized, placebo-controlled phase II study of Eculizumab in patients with refractory generalized myasthenia gravis Muscle Nerve 48 2013 76 84